Research and Markets: EpiCast Report: Multiple Sclerosis Study 2015 - Epidemiology Forecast to 2024
November 27 2015 - 10:20AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/9xqz4f/epicast_report)
has announced the addition of the "EpiCast Report: Multiple
Sclerosis - Epidemiology Forecast to 2024" report to their
offering.
Multiple sclerosis (MS) is an inflammatory disease in which the
myelin sheaths around the axons of the brain and spinal cord are
damaged, leading to demyelination and a wide range of signs and
symptoms. The course of MS seems to be unpredictable as some people
diagnosed with the condition appear to be normal and healthy for a
few years after diagnosis, while others may be debilitated very
quickly after diagnosis. People with MS experience a host of
symptoms, which may vary with the course of the disease. The
estimated prevalence and incidence of MS vary greatly between
countries, within countries, and by age and sex.
In 2014, there were a total of 909,398 diagnosed prevalent cases
of MS in the 10MM, and GlobalData epidemiologists forecast that by
2024, the number of diagnosed prevalent cases of MS will grow to
942,567 cases. In 2014, there were a total of 60,535 diagnosed
incident cases of MS in the 10MM, and GlobalData epidemiologists
forecast the number of diagnosed incident cases of MS to grow to
62,635 cases in the 10MM in 2024.
Scope
- The Multiple Sclerosis (MS) EpiCast Report provides an
overview of the risk factors, comorbidities, and global trends for
MS in the ten major markets (10MM) (US, France, Germany, Italy,
Spain, UK, Japan, Canada, China, and India). It includes a 10-year
epidemiological forecast of the diagnosed prevalent and diagnosed
incident cases of MS segmented by sex and age in these markets.
This report also includes a discussion of three types of MS;
relapse remitting (RRMS), primary progressive (PPMS), and secondary
progressive (SPMS).
- The MS epidemiology report is written and developed by
Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and
market-driven, providing expert analysis of disease trends in the
10MM.
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global Trends
3.4 Forecast Methodology
3.5 Epidemiological Forecast for MS (2014-2024)
3.6 Discussion
4 Appendix
For more information visit
http://www.researchandmarkets.com/research/9xqz4f/epicast_report
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005283/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Central Nervous System